Association between the androgen levels and erectile function, cognitive functions and hypogonadism symptoms in aging males

References

• David E. Bloom, David Canning, Günther Fink. The Graying of global population and its macroeconomic consequences. October 2009 PGDA working paper no. 47. Available at: http://www.hsph.harvard.edu/pgda/working.htm.
   Google Scholar
• Morales A, Heaton JP, Carson CC 3rd. Andropause: A misnomer for a true clinical entity. J Urol 2000;163:705–712.
   Google Scholar
• Ferrini RL, Barrett-Connor E. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;147:750–754.
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab 2001;86:724–731.
   PubMed Web of Science ®Google Scholar
• Tajar A, Forti G, O’Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, et al. EMAS Group. Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European Male ageing study. J Clin Endocrinol Metab 2010;95:1810–1818.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, et al. EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123–135.
   PubMed Web of Science ®Google Scholar
• Arianayagam R, Arianayagam M, McGrath S, Rashid P. Androgen deficiency in the aging man. Aust Fam Physician 2010;39:752–755.
   Google Scholar
• Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12.
   PubMed Web of Science ®Google Scholar
• Morales A, Lunenfeld B. Standards, guidelines and recommendations of the International Society for the Study of the Aging Male (ISSAM). The Aging Male 2002;5:74–86.
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–3672.
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC. Investigation, treatment and monitoring of lateonset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 2005;28:125–127.
   Google Scholar
• Canguven O, Gurkan L, Horuz R, Albayrak S, Kadioglu A. Yaslanan erkek semptom sorgulama formu: Turkce gecerlilik calismasi (validity study for the Turkish version of symptom investigating form in aging males). Androloji Bulteni 2005;21:93–98.
   Google Scholar
• Heinemann LA, Saad F, Heinemann K, Thai DM. Can results of the aging Males’ symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging Male 2004;7:211–218.
   PubMedGoogle Scholar
• Gungen C, Ertan T. Standardize mini mental test’in Turk Toplumunda Hafif Demans Tanisinda Gecerlik ve Guvenilirligi (validity and reliability study on standardized mini mental test for the diagnosis of mild dementia in the Turkish Society). Turk Psikiyatri Dergisi 2002;13:273–281.
   PubMedGoogle Scholar
• Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–830.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007;116:2694–2701.
   PubMed Web of Science ®Google Scholar
• Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004;350:482–492.
   PubMed Web of Science ®Google Scholar
• Liverman CT, Blazer DG, Eds. Testosterone and aging. Washington, DC: Institute of Medicine, National Academies Press; 2004.
   Google Scholar
• Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833–876.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–598.
   PubMed Web of Science ®Google Scholar
• Wu FC. Commentary: Guideline for male testosterone therapy: A European perspective. J Clin Endocrinol Metab 2007;92:418–419.
   PubMed Web of Science ®Google Scholar
• Shames D, Gassman A, Handelsman H. Commentary: Guideline for male testosterone therapy: A regulatory perspective. J Clin Endocrinol Metab 2007;92:414–415.
   PubMed Web of Science ®Google Scholar
• Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007;92:4241–4247.
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Wruck LM, Kupelian V, O’Donnell AB, McKinlay JB. Assessment of screening evaluations is not straightforward. Maturitas 2006;54:305–308.
   Google Scholar
• Handelsman DJ, Liu PY. Andropause: Invention, prevention, rejuvenation. Trends Endocrinol Metab 2005;16:39–45.
   PubMedGoogle Scholar
• Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 2006;27:135–137.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995–2010.
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335–4343.
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Kupelian V, O’Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 2007;92:549–555.
   PubMed Web of Science ®Google Scholar
• Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, et al. Testosterone and estradiol among older men. J Clin Endocrinol Metab 2006;91:1336–1344.
   PubMed Web of Science ®Google Scholar
• Moore C, Huebler D, Zimmermann T, Heinemann LA, Saad F, Thai DM. The aging Males’ symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004;46:80–87.
   PubMed Web of Science ®Google Scholar
• T’Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004;29:201–214.
   PubMed Web of Science ®Google Scholar
• Kapoor D, Clarke S, Channer KS, Jones TH. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl 2007;30:500–507.
   PubMed Web of Science ®Google Scholar
• La Vignera S, Condorelli R, Vicari E, D’Agata R, Calogero A. Physical activity and erectile dysfunction in middle-aged men: A brief review. J Androl 2011. [ePub ahead of print].
   Google Scholar
• Kratzik CW, Schatzl G, Lunglmayr G, Rücklinger E, Huber J. The impact of age, body mass index and testosterone on erectile dysfunction. J Urol 2005;174:240–243.
   PubMed Web of Science ®Google Scholar
• Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, et al. Effects of testosterone on sexual function in men: Results of a meta-analysis. Clin Endocrinol (Oxf) 2005;63:381–394.
   PubMed Web of Science ®Google Scholar
• Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002;87:5001–5007.
   PubMed Web of Science ®Google Scholar
• Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 2000;12:407–414.
   PubMed Web of Science ®Google Scholar